SCHEMBL10707367

SCHEMBL10707367

Cc1c(C(C)(C)C)cc(O)c(O)c1C(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.52
ALDH1A1 P00352 6/20 0.52
ALOX15 P16050 5/20 0.52
CYP1A2 P05177 2/20 0.52
MAPT P10636 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ATP2A2 P16615 1/20 0.52
ATP2A3 Q93084 1/20 0.52
CA2 P00918 4/20 0.46
TYR P14679 2/20 0.46
POLB P06746 1/20 0.46
CA1 P00915 2/20 0.43
CYP2C9 P11712 4/20 0.42
CYP2C19 P33261 3/20 0.42
TP53 P04637 3/20 0.39
LMNA P02545 3/20 0.39
CYP3A4 P08684 2/20 0.39
HPGD P15428 1/20 0.39
HIF1A Q16665 3/20 0.39
PTGS1 P23219 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13400274 0.84 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL28404267 0.84 ALOX15 (0.54) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL28751257 0.84 ALOX15 (0.54) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL31424079 0.83 CYP2C19 (0.52) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL1882430 0.83 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL1476812 0.83 CYP2C19 (0.52) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL9132733 0.82 SELL (0.40) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL2221169 0.82 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL30615138 0.81 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT
SCHEMBL2244012 0.80 ALOX15 (0.54) SMN1; SMN2ALDH1A1ALOX15CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1702675-B1 CONTINUOUS MULTI-MICROENCAPSULATION PROCESS FOR IMPROVING THE STABILITY AND STORAGE LIFE OF BIOLOGICALLY ACTIVE INGREDIENTS GAT MICROENCAPSULATION GMBH (AT) 2016-09-21 EP claimed
EP-0106169-B1 SUBSTITUTED 2-(2,6-DI-T-BUTYL-4-ALKYLPHENOXY) 4H-1,3,2-BENZODIOXAPHOSPHORINS AND COMPOSITIONS THEREOF The B.F. GOODRICH Company (US) 1988-01-07 EP disclosed